Keyword: Abbreviated New Drug Application (ANDA)

News

FDA Approves Mylan’s Yasmin Copies

11.09.2015 - Following approval from the US Food and Drug Administration (FDA), Netherlands-domiciled Mylan has launched generic copies of Bayer's drospirenone and ethinyl estradiol-based...

News

Alvogen to buy Pfizer Drugs for US Market

28.08.2015 - US pharma company Alvogen has agreed to buy four of Pfizer’s products in the USA. The sale is part of Pfizer’s condition in closing its $17 billion acquisition of Hospira. The...

News

US Grants Priority Review for Shire’s Lifitegrast Dry Eye Treatment

10.04.2015 - The US Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) from Shire for its lifitegrast dry eye treatment for adults and has designated it as a Priority...

Plant Construction & Process Technology

GDUFA’s Impact on the API Industry – an Update

02.04.2014 - The Price of Doing Business - Following the 2012 implementation of the Generic Drug User Fee Act (GDUFA), an article in CHEManager Europe's July/August 2013 edition about GDUFA's...

Plant Construction & Process Technology

GDUFA’s Impact on the API Industry

06.08.2013 - One-Time Fee - On Oct. 1, 2012, the U. S. Food and Drug Administration (FDA) implemented the long-discussed Generic Drug User Fee Act (GDUFA) , thereby authorizing the agency to...

Plant Construction & Process Technology

API Sourcing in China and India

19.10.2011 - Paradigm Shift - The number of API manufacturers in India and China focused on supplying active ingredients to regulated markets has grown considerably over the past few years...